Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T07:51:57.568Z Has data issue: false hasContentIssue false
  • English
  • Français

Improving Pain Management through Policy Making and Education for Medical Regulators

Published online by Cambridge University Press:  01 January 2021

David E. Joranson  and
Aaron M. Gilson
Get access Rights & Permissions [Opens in a new window]

Extract

Physician concern about regulatory scrutiny as a barrier to appropriate prescribing for pain management has been identified and studied. A 1991 Pain Research Group survey demonstrated a need to provide updated information about opioids and pain management to state medical board members. Indeed, a national survey even showed a need to provide more education about pain management to oncology Physicians. Two approaches for responding to these concerns have been undertaken in several states by the state medical boards and the pain management community: the development and adoption of administrative policies designed to bring disciplinary standards in line with clinical practice; and the creation of education programs for state medical board members and staffs. Each can have a substantial impact on removing real and perceived regulatory barriers to effective pain relief.

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 24 , Issue 4 , Winter 1996 , pp. 344 - 347
Copyright
Copyright © American Society of Law, Medicine and Ethics 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hill, C.S., “The Negative Influence of Licensing and Disciplinary Boards and Drug Enforcement Agencies on Pain Treatment with Opioid Analgesics,” Journal of Pharmaceutical Care in Pain and Symptom Control, 1 (1993): 43–62; Max, M.B., “Improving Outcomes of Analgesic Treatment: Is Education Enough?,” Annals of Internal Medicine, 113 (1990): 885–89; “Cops and Doctors: Drug Busts Hamper Pain Therapy,” Journal of NIH Research, 4, no. 5 (1992): 27–28; Portenoy, R.K., “Chronic Opioid Therapy in Nonmalignant Pain,” Journal of Pain and Symptom Management, 5 (1990): 46–62; Turk, D.C. Brody, M.C., “What Position Do APS's Physician Members Take on Chronic Pain Opioid Therapy?,” American Pain Society Bulletin, 2, no. 2 (1992): 1–5; Turk, D.C. Brody, M.C. Okifuji, E.A., “Physicians' Attitudes and Practices Regarding the Long-Term Prescribing of Opioids for Non-Cancer Pain,” Pain, 59 (1994): 201–08; and Weissman, D.E. Joranson, D.E. Hopwood, M.B., “Wisconsin Physicians' Knowledge and Attitudes About Opioid Analgesic Regulations,” Wisconsin Medical Journal, 90 (1991): 671–75.CrossRefGoogle Scholar
Joranson, D.E.et al, “Opioids for Chronic Cancer and Non-Cancer Pain: A Survey of State Medical Board Members,” Federation Bulletin: The Journal of Medical Licensure and Discipline, 79, no. 4 (1992): 15–49.Google Scholar
Von Roenn, J.H.et al, “Results of Physicians' Attitudes Toward Cancer Pain Management Survey,” Proceedings of American Society of Clinical Oncology, 10 (1991): 326.Google Scholar
Portenoy, R.K., “Opioids for Chronic Nonmalignant Pain: A Review of the Critical Issues,” Journal of Pain and Symptom Management, 5 (1996): 203-17; Portenoy, R.K. Payne, R., “Acute and Chronic Pain,” in Lowinson, J.H. Ruiz, P. Millman, R.B., eds., Comprehensive Textbook of Substance Abuse (Baltimore: Williams and Wilkins, 3rd ed., 1997): In press.Google Scholar
The following state medical boards have adopted guidelines: Alabama State Board of Medical Examiners, Pain Control Policy (1994); Alaska State Medical Licensing Board, Guidelines for Prescribing Controlled Substances (June 1993); Arizona Board of Medical Examiners, “Guidelines for Prescribing Controlled Substances for Intractable Pain,” Bomex Basics, Summer (1991): 1–2; Medical Board of California, “A Statement by the Medical Board,” Action Report, 50 (1994): 4–5; Colorado Board of Medical Examiners, Guidelines for Prescribing Controlled Substances for Intractable Pain (May 1996); Florida Board of Medicine, “Practice and Regulatory Guidelines,” Management of Pain Using Dangerous Drugs and Controlled Substances, Oct. 25 (1996): 5–7; Georgia Composite State Board of Medical Examiners, Management of Prescribing with Emphasis on Addictive or Dependence Producing Drugs (1991); Idaho State Board of Medicine, Guideline: Prescribing Opioids for Chronic Pain (1995); Maryland Board of Physician Quality Assurance, “Prescribing Controlled Drugs,” Maryland Board of Physician Quality Assurance Newsletter, 4, no. 1 (1996): 1–3; Massachusetts Board of Registration in Medicine, “Prescribing Practices Policy and Guidelines Adopted,” News, 4 (1989): 1–2; Minnesota Board of Medical Examiners, “Prescribing Within a Range of Reasonableness,” Minnesota Board of Medical Examiners Update, Fall (1988): 1–2, 5; Montana Board of Medical Examiners, Management of Chronic Pain: Statement on the Use of Controlled Substances in the Treatment of Intractable Pain, at 3–4 (Mar. 1996); North Carolina Medical Board, Management of Chronic Non-Malignant Pain (Sept. 1996); Oregon Board of Medical Examiners, Statement of Philosophy: Appropriate Prescribing of Controlled Substances (May 1991); Stasney, C.R. Hill, C.S., “Pain Control and the Texas State Board of Medical Examiners,” Texas State Board of Medical Examiners Newsletter, Spring/Summer (1993): 1; Utah Medical Association, A Guide to Prescribing Controlled Substances in Utah (1987); Washington Medical Quality Assurance Commission, Guidelines for Management of Pain (Apr. 1996); and Wyoming Board of Medicine, “Pitfalls of Prescribing Controlled Substances,” Wyoming Board of Medicine's Newsletter, Spring (1993).Google Scholar
See Joranson, et al, supra note 2, at 31–32.Google Scholar
Oregon Board of Medical Examiners, supra note 5, at 1.Google Scholar
Medical Board of California, “New Easy Guidelines on Prescribing,” Action Report, 51 (1994): 1, 8.Google Scholar
A drug holiday is a decision by a physician to stop the use of a prescribed drug in an effort (1) to determine whether it is still necessary and (2) to reassess a patient's pain.Google Scholar
Triplicate drugs require practitioners to use special government-issued prescription forms, which can be either single, duplicate, or triplicate copy.Google Scholar
Medical Board of California, “Statement by the Medical Board,” Action Report, 50 (1993): At 4–5.Google Scholar
“California Sponsors Pain Summit; Maryland Fends Off New Regulations,” American Pain Society Bulletin 4, no. 3 (1994): 11–12.Google Scholar
California Medical Board, supra note 8.Google Scholar
California Medical Board, “A Statement by the Medical Board: Prescribing Controlled Substances for Pain,” Federation Bulletin: The Journal of Medical Licensure and Discipline, 81, no. 3 (1994): 203-05; California Medical Board, “Guideline for Prescribing Controlled Substances for Intractable Pain,” Action Report, 51 (1994): 1, 8; and American Pain Society, “APS OKs California Pain Treatment Guidelines,” American Pain Society Bulletin, 5, no. 2 (1995): 20–21.Google Scholar
See American Pain Society, id.Google Scholar
Board of Registered Nursing, “Pain Management Policy. Summit on Effective Pain Management: Removing Impediments to Appropriate Prescribing,” at 42 (1994). California State Board of Pharmacy, “Dispensing Controlled Substances for Pain: A Statement of the California State Board of Pharmacy,” Health Notes, (1996): 4–5.Google Scholar
Florida Board of Medicine, supra note 5.Google Scholar
North Carolina Medical Board, supra note 5.Google Scholar
Washington Medical Quality Assurance Commission, Management of Chronic Non-Malignant Pain (Seattle: Department of Health, Apr. 1996).Google Scholar
American Academy of Pain Medicine and American Pain Society, “The Use of Opioids for the Treatment of Chronic Pain. A Consensus Statement from the American Academy of Pain Medicine and the American Pain Society” (1997).Google Scholar
Washington v. Glucksberg, 117 S. Ct. 37 (1996) (granting cert.); and Quill v. Vacco, 117 S. Ct. 36 (1996) (granting cert.).Google Scholar
American Medical Association, An Act Concerning the Administration of Controlled Substances to Persons Experiencing Intractable Pain (1996).Google Scholar
Joranson, D.E., “State Pain Commissions: New Vehicles for Progress?,” American Pain Society Bulletin, 6, no. 1 (1996): 7–9.Google Scholar
Faculty included Dahl, June L., Ph.D. Brady, Albert, M.D. David Haddox, J., D.D.S., M.D. Savage, Seddon M.D., and Joranson, David M.S.S.W.Google Scholar
North Carolina Medical Board, supra note 5; and Alabama State Board of Medical Examiners, 540-X-4-.08, at 4-30-4-32 (Mar. 1995).Google Scholar